Sharon R. Letchworth

1.4k total citations
27 papers, 1.1k citations indexed

About

Sharon R. Letchworth is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Sharon R. Letchworth has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Sharon R. Letchworth's work include Receptor Mechanisms and Signaling (20 papers), Nicotinic Acetylcholine Receptors Study (14 papers) and Neuroscience and Neuropharmacology Research (11 papers). Sharon R. Letchworth is often cited by papers focused on Receptor Mechanisms and Signaling (20 papers), Nicotinic Acetylcholine Receptors Study (14 papers) and Neuroscience and Neuropharmacology Research (11 papers). Sharon R. Letchworth collaborates with scholars based in United States, France and Canada. Sharon R. Letchworth's co-authors include Linda J. Porrino, Merouane Bencherif, Hilary R. Smith, Michael A. Nader, David P. Friedman, Gavril W. Pasternak, John P. Mathis, Jerry J. Buccafusco, Grace C. Rossi and Jennifer P. Ryan‐Moro and has published in prestigious journals such as Journal of Neuroscience, The Journal of Comparative Neurology and Brain Research.

In The Last Decade

Sharon R. Letchworth

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon R. Letchworth United States 18 745 718 198 164 131 27 1.1k
Manolo Mugnaini Italy 19 881 1.2× 996 1.4× 135 0.7× 119 0.7× 164 1.3× 28 1.4k
Mary Cohen-Williams United States 17 441 0.6× 445 0.6× 136 0.7× 108 0.7× 87 0.7× 28 892
Richard Loiacono Australia 19 705 0.9× 571 0.8× 200 1.0× 145 0.9× 76 0.6× 33 1.1k
Karla Drescher Germany 17 488 0.7× 607 0.8× 77 0.4× 166 1.0× 149 1.1× 31 1.0k
Christopher M. de Fiebre United States 22 1.1k 1.5× 755 1.1× 231 1.2× 255 1.6× 126 1.0× 37 1.5k
P. Malherbe Switzerland 11 555 0.7× 481 0.7× 102 0.5× 80 0.5× 143 1.1× 15 973
D Lodge United Kingdom 14 811 1.1× 1.1k 1.6× 240 1.2× 154 0.9× 175 1.3× 26 1.5k
Feng Yi United States 15 611 0.8× 844 1.2× 119 0.6× 87 0.5× 193 1.5× 32 1.2k
Vicki L. Coffin United States 21 676 0.9× 998 1.4× 98 0.5× 155 0.9× 211 1.6× 41 1.4k
S.N. Mitchell United Kingdom 15 512 0.7× 610 0.8× 69 0.3× 161 1.0× 179 1.4× 19 949

Countries citing papers authored by Sharon R. Letchworth

Since Specialization
Citations

This map shows the geographic impact of Sharon R. Letchworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon R. Letchworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon R. Letchworth more than expected).

Fields of papers citing papers by Sharon R. Letchworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon R. Letchworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon R. Letchworth. The network helps show where Sharon R. Letchworth may publish in the future.

Co-authorship network of co-authors of Sharon R. Letchworth

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon R. Letchworth. A scholar is included among the top collaborators of Sharon R. Letchworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon R. Letchworth. Sharon R. Letchworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Danhui, David Sohn, F. Ivy Carroll, et al.. (2013). Nicotinic Receptor Agonists Reduce l-DOPA–Induced Dyskinesias in a Monkey Model of Parkinson's Disease. Journal of Pharmacology and Experimental Therapeutics. 347(1). 225–234. 39 indexed citations
2.
Quik, Maryka, Carla Cristian Campos, Tanuja Bordia, et al.. (2013). α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats. Neuropharmacology. 71. 191–203. 39 indexed citations
3.
Loram, Lisa C., Frederick R. Taylor, Keith A. Strand, et al.. (2012). Systemic Administration of an Alpha-7 Nicotinic Acetylcholine Agonist Reverses Neuropathic Pain in Male Sprague Dawley Rats. Journal of Pain. 13(12). 1162–1171. 42 indexed citations
5.
Zhang, Shuai, Yun-De Xiao, Kristen G. Jordan, et al.. (2012). Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: Correlation with desensitization of α4β2* receptors. European Journal of Pharmaceutical Sciences. 47(5). 813–823. 16 indexed citations
7.
Hauser, Terry A., David C. Kombo, Vladimir P. Grinevich, et al.. (2012). Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine. Neuropharmacology. 62(7). 2239–2250. 37 indexed citations
8.
Lippiello, Patrick M., et al.. (2006). Ispronicline: A Novel α4β2 Nicotinic Acetylcholine Receptor-Selective Agonist With Cognition-Enhancing and Neuroprotective Properties. Journal of Molecular Neuroscience. 30(1-2). 19–20. 20 indexed citations
9.
Grinevich, Vladimir P., Sharon R. Letchworth, Jean Ménager, et al.. (2005). Heterologous Expression of Human α6β4β3α5 Nicotinic Acetylcholine Receptors: Binding Properties Consistent with Their Natural Expression Require Quaternary Subunit Assembly Including the α5 Subunit. Journal of Pharmacology and Experimental Therapeutics. 312(2). 619–626. 32 indexed citations
10.
Gatto, Gregory J., Georg Andrees Böhme, William S. Caldwell, et al.. (2004). TC‐1734: An Orally Active Neuronal Nicotinic Acetylcholine Receptor Modulator with Antidepressant, Neuroprotective and Long‐Lasting Cognitive Effects. CNS Drug Reviews. 10(2). 147–166. 90 indexed citations
11.
Rouden, Jacques, Laurent Besret, Héric Valette, et al.. (2003). Synthesis of a [2-Pyridinyl-18F]-labelled fluoro derivative of (−)-Cytisine as a candidate radioligand for brain nicotinic α4β2 receptor imaging with PET. Bioorganic & Medicinal Chemistry. 11(24). 5333–5343. 29 indexed citations
12.
Letchworth, Sharon R., Michael A. Nader, Hilary R. Smith, David P. Friedman, & Linda J. Porrino. (2001). Progression of Changes in Dopamine Transporter Binding Site Density as a Result of Cocaine Self-Administration in Rhesus Monkeys. Journal of Neuroscience. 21(8). 2799–2807. 183 indexed citations
13.
Daunais, James B., Sharon R. Letchworth, Laura J. Sim‐Selley, et al.. (2001). Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate. The Journal of Comparative Neurology. 433(4). 471–485. 37 indexed citations
14.
Letchworth, Sharon R., Hilary R. Smith, Linda J. Porrino, et al.. (2000). Characterization of a Tropane Radioligand, [3H]2β-Propanoyl-3β-(4-tolyl) Tropane ([3H]PTT), for Dopamine Transport Sites in Rat Brain. Journal of Pharmacology and Experimental Therapeutics. 293(2). 686–696. 10 indexed citations
15.
Letchworth, Sharon R., John P. Mathis, Grace C. Rossi, Richard J. Bodnar, & Gavril W. Pasternak. (2000). Autoradiographic localization of 125I[Tyr14]orphanin FQ/nociceptin and 125I[Tyr10]orphanin FQ/nociceptin(1–11) binding sites in rat brain. The Journal of Comparative Neurology. 423(2). 319–329. 3 indexed citations
16.
Mathis, John P., et al.. (1999). Identification of a high-affinity orphanin FQ/nociceptin(1-11) binding site in mouse brain. Synapse. 34(3). 181–186. 19 indexed citations
17.
Daunais, James B., Stacey L. Hart, Hilary R. Smith, et al.. (1998). Long-Acting Blockade of Biogenic Amine Transporters in Rat Brain by Administration of the Potent Novel Tropane 2β-Propanoyl-3β-(2-Naphthyl)-Tropane. Journal of Pharmacology and Experimental Therapeutics. 285(3). 1246–1254. 7 indexed citations
18.
Rossi, Grace C., Sharon R. Letchworth, John P. Mathis, et al.. (1998). Pharmacological characterization of Endomorphin-1 and Endomorphin-2 in Mouse Brain. Journal of Pharmacology and Experimental Therapeutics. 286(2). 1007–1013. 166 indexed citations
19.
Daunais, James B., Stephanie Hart, Hilary R. Smith, et al.. (1998). Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2beta-propanoyl-3beta-(2-Naphthyl)-tropane.. PubMed. 285(3). 1246–54. 14 indexed citations
20.
Letchworth, Sharon R., et al.. (1997). Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Brain Research. 750(1-2). 214–222. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026